Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
o2h Ventures investment portfolio
o2h Ventures has made numerous investments in companies such as Turbine Simulated Cell Technologies, Stratosvir, and Kuano within the Biotech sector.
vc
Portfolio
19
Team
0
Portfolio (19)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Alevin Therapeutics Limited Alevin Therapeutics is a biotechnology company developing targeted integrin inhibitor medicines for fibrotic diseases, including idiopathic pulmonary fibrosis. | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-03-10 |
| Bivictrix Therapeutics Limited BiVictriX Therapeutics develops next‑generation multispecific antibody‑drug conjugates (ADCs) using its proprietary Bi‑Cygni® platform to create highly cancer‑selective therapies for solid tumours and haematological malignancies. | Healthcare & Life Sciences | Macclesfield | Confirmed | 2025-06-21 |
Shareholding changes (16)
O2h Nominees Limited (On Behalf Of O2h Ventures Limited)'s positions across portfolio companies2026
- ORDINARY 0 → 1,289,600
- A2 ORDINARY 17,663 → 19,470
Articles (6)
- Revolver Therapeutics secures £572k for peptide-based cancer inhibitors24 Jun 2026Revolver Therapeutics
- 11 Jun 2026
- Liquid Ventures I LP joins Cardiatec Biosciences as LQD Ventures exits10 Jun 2026Cardiatec Biosciences
- Camgene Therapeutics secures £260k Series A funding for hearing loss treatments19 May 2026Camgene Therapeutics
- 12 May 2026
- Turbine Simulated Cell Technologies raises £22.8m Series B for AI drug discovery platform9 May 2026Turbine Simulated Cell Technologies